StudzPeptides Review & Prices

5-Amino-1MQ is a small-molecule inhibitor of nicotinamide N-methyltransferase (NNMT) . Unlike peptide compounds, it is a quinolinium-based molecule studied mainly in cell and animal models to understand NNMT activity, methylation metabolism, and related NAD+ pathways. Current evidence remains preclinical , with no established human clinical profile.

Adamax is a good example of how fast this market moves. It showed up on vendor sites a couple of years ago as a "stronger Semax ," and nearly every page describing it repeats the same lines. When I went looking for primary literature on Adamax itself, I couldn't find any. What exists is the research on its two parent compounds, and a design idea that borrows from both. I'll lay out what's known, what's borrowed, and what's just marketing. On Peptide Grading , we list the research-labeled vials with sizes, price per mg, and COAs side by side. A listing doesn't mean any of the claims below have been shown.

A copper-binding tripeptide studied mainly in skin, hair-follicle, extracellular-matrix and cosmetic research.

ARA-290 (cibinetide) is an 11-amino-acid peptide designed from part of erythropoietin (EPO). It targets the innate repair receptor to study tissue-protective and anti-inflammatory effects, without EPO's effect of raising red blood cell counts.

BPC-157 is a 15-amino-acid peptide first described from gastric juice. Most of the published work is preclinical, with studies covering tendon, muscle, gastrointestinal, vascular, and other injury models. Researchers have looked at several signaling pathways, including VEGFR2, nitric oxide, Akt-eNOS, and ERK1/2 . Other work has focused on angiogenesis, fibroblast activity, endothelial responses, and inflammation. Human data are still sparse. Small studies have looked at knee pain, interstitial cystitis, and intravenous safety and pharmacokinetics , but the number of human studies remains small and larger controlled trials are not available.

A BPC-157 and TB-500 blend, often called the "Wolverine Stack" is an informal combination of two synthetic peptides studied for tissue repair, cellular movement, and recovery

Cagrilintide is based on amylin , a hormone that helps regulate appetite and blood sugar after eating. Its structure was modified from natural amylin to make the peptide last longer. Unlike semaglutide, which mainly targets the GLP-1 receptor , cagrilintide acts through amylin and calcitonin-family receptors . Cagrilintide has also been studied on its own and together with semaglutide. Peptide Grading lists cagrilintide research materials from different suppliers. Listings can include supplier details, reported specifications, COA, quantities, shipping information, and price per mg .

A research blend combining a short-acting GHRH analogue with a ghrelin-receptor agonist to study pulsatile growth-hormone signaling.

Dihexa is a synthetic compound derived from angiotensin IV . It was developed to be more stable in the body than the original peptide. Most of the early research around Dihexa has looked at the HGF/c-Met pathway, along with changes in synapses and memory-related behavior in experimental models. Dihexa also stands apart from many of the research peptides that are commonly discussed today. It is not simply a copy of a naturally occurring peptide. Instead, it was designed by modifying the structure of angiotensin IV, giving researchers a different compound to study in laboratory.

A nonapeptide studied for sleep architecture, stress response and neuroendocrine signaling, with mixed human evidence.